Chung Ka-Fai, Yeung Wing-Fai, Ho Fiona Yan-Yee, Yung Kam-Ping, Yu Yee-Man, Kwok Chi-Wa
Department of Psychiatry, The University of Hong Kong, Hong Kong SAR, China.
School of Chinese Medicine, The University of Hong Kong, Hong Kong SAR, China.
Sleep Med. 2015 Apr;16(4):477-82. doi: 10.1016/j.sleep.2014.10.018. Epub 2015 Jan 21.
To compare the prevalence of insomnia according to symptoms, quantitative criteria, and Diagnostic and Statistical Manual of Mental Disorders, 4th and 5th Edition (DSM-IV and DSM-5), International Classification of Diseases, 10th Revision (ICD-10), and International Classification of Sleep Disorders, 2nd Edition (ICSD-2), and to compare the prevalence of insomnia disorder between Hong Kong and the United States by adopting a similar methodology used by the America Insomnia Survey (AIS).
Population-based epidemiological survey respondents (n = 2011) completed the Brief Insomnia Questionnaire (BIQ), a validated scale generating DSM-IV, DSM-5, ICD-10, and ICSD-2 insomnia disorder.
The weighted prevalence of difficulty falling asleep, difficulty staying asleep, waking up too early, and non-restorative sleep that occurred ≥3 days per week was 14.0%, 28.3%, 32.1%, and 39.9%, respectively. When quantitative criteria were included, the prevalence dropped the most from 39.9% to 8.4% for non-restorative sleep, and the least from 14.0% to 12.9% for difficulty falling asleep. The weighted prevalence of DSM-IV, ICD-10, ICSD-2, and any of the three insomnia disorders was 22.1%, 4.7%, 15.1%, and 22.1%, respectively; for DSM-5 insomnia disorder, it was 10.8%.
Compared with 22.1%, 3.9%, and 14.7% for DSM-IV, ICD-10, and ICSD-2 in the AIS, cross-cultural difference in the prevalence of insomnia disorder is less than what is expected. The prevalence is reduced by half from DSM-IV to DSM-5. ICD-10 insomnia disorder has the lowest prevalence, perhaps because excessive concern and preoccupation, one of its diagnostic criteria, is not always present in people with insomnia.
根据症状、定量标准以及《精神疾病诊断与统计手册》第4版和第5版(DSM-IV和DSM-5)、《国际疾病分类》第10版(ICD-10)和《国际睡眠障碍分类》第2版(ICSD-2)比较失眠的患病率,并采用美国失眠调查(AIS)所使用的类似方法比较香港和美国失眠症的患病率。
基于人群的流行病学调查受访者(n = 2011)完成了简易失眠问卷(BIQ),这是一个经过验证的量表,可生成DSM-IV、DSM-5、ICD-10和ICSD-2失眠症。
每周发生≥3天的入睡困难、睡眠维持困难、早醒和非恢复性睡眠的加权患病率分别为14.0%、28.3%、32.1%和39.9%。当纳入定量标准时,患病率下降幅度最大的是非恢复性睡眠,从39.9%降至8.4%,下降幅度最小的是入睡困难,从14.0%降至12.9%。DSM-IV、ICD-10、ICSD-2以及这三种失眠症中任何一种的加权患病率分别为22.1%、4.7%、15.1%和22.1%;DSM-5失眠症的加权患病率为10.8%。
与AIS中DSM-IV、ICD-10和ICSD-2的22.1%、3.9%和14.7%相比,失眠症患病率的跨文化差异小于预期。从DSM-IV到DSM-5,患病率降低了一半。ICD-10失眠症的患病率最低,可能是因为其诊断标准之一的过度担忧和全神贯注在失眠患者中并不总是存在。